Class information for:
Level 1: MONOCLONAL ANTIBODY HUMAN//HETEROHYBRIDOMA//IDIOTYPE ACTIVITY

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
12091 868 27.8 54%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
3176 1625 REG PROTEIN//PANCREATITIS ASSOCIATED PROTEIN//NEURONAL THREAD PROTEIN

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MONOCLONAL ANTIBODY HUMAN Author keyword 8 62% 1% 8
2 HETEROHYBRIDOMA Author keyword 4 40% 1% 8
3 IDIOTYPE ACTIVITY Author keyword 3 100% 0% 3
4 MINI ELECTROFUSION Author keyword 3 100% 0% 3
5 TI 23 Author keyword 3 100% 0% 3
6 HUMAN MONOCLONAL ANTIBODY Author keyword 3 12% 3% 22
7 ANTIGEN SPECIFIC B CELL Author keyword 3 60% 0% 3
8 INVITRO IMMUNIZATION Author keyword 3 42% 1% 5
9 HYBRIDOMA HUMAN Author keyword 2 67% 0% 2
10 IMMUNOTHERAPEUTIC AGENT Author keyword 2 50% 0% 3

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 MONOCLONAL ANTIBODY HUMAN 8 62% 1% 8 Search MONOCLONAL+ANTIBODY++HUMAN Search MONOCLONAL+ANTIBODY++HUMAN
2 HETEROHYBRIDOMA 4 40% 1% 8 Search HETEROHYBRIDOMA Search HETEROHYBRIDOMA
3 IDIOTYPE ACTIVITY 3 100% 0% 3 Search IDIOTYPE+ACTIVITY Search IDIOTYPE+ACTIVITY
4 MINI ELECTROFUSION 3 100% 0% 3 Search MINI+ELECTROFUSION Search MINI+ELECTROFUSION
5 TI 23 3 100% 0% 3 Search TI+23 Search TI+23
6 HUMAN MONOCLONAL ANTIBODY 3 12% 3% 22 Search HUMAN+MONOCLONAL+ANTIBODY Search HUMAN+MONOCLONAL+ANTIBODY
7 ANTIGEN SPECIFIC B CELL 3 60% 0% 3 Search ANTIGEN+SPECIFIC+B+CELL Search ANTIGEN+SPECIFIC+B+CELL
8 INVITRO IMMUNIZATION 3 42% 1% 5 Search INVITRO+IMMUNIZATION Search INVITRO+IMMUNIZATION
9 HYBRIDOMA HUMAN 2 67% 0% 2 Search HYBRIDOMA++HUMAN Search HYBRIDOMA++HUMAN
10 IMMUNOTHERAPEUTIC AGENT 2 50% 0% 3 Search IMMUNOTHERAPEUTIC+AGENT Search IMMUNOTHERAPEUTIC+AGENT

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 HUMAN HYBRIDOMAS 13 50% 2% 19
2 INVITRO IMMUNIZATION 12 54% 2% 15
3 HETEROHYBRIDOMAS 3 43% 1% 6
4 INTERSPECIES FUSION 2 43% 0% 3
5 ENZYME IMMUNOFILTRATION 1 100% 0% 2
6 LUNG MICROVASCULAR ENDOTHELIUM 1 50% 0% 2
7 MURINE BOVINE HYBRIDOMAS 1 100% 0% 2
8 TRANSFORMED LYMPHOCYTES 1 29% 0% 4
9 HUMAN HUMAN HYBRIDOMAS 1 16% 1% 7
10 ANTIBODY PRODUCING HYBRIDOMAS 1 40% 0% 2

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
HUMAN MONOCLONAL-ANTIBODY PRODUCTION - CURRENT STATUS AND FUTURE-PROSPECTS 1987 153 158 66%
Veterinary sources of nonrodent monoclonal antibodies: Interspecific and intraspecific hybridomas 2000 20 119 34%
HUMAN MONOCLONAL-ANTIBODIES 1988 41 44 80%
STRATEGY FOR THE PRODUCTION OF HUMAN MONOCLONAL-ANTIBODIES USING INVITRO ACTIVATED B-CELLS 1989 42 27 48%
Development of human monoclonal antibodies: A review 1996 2 67 79%
Receptors and signaling mechanisms for B-lymphocyte activation, proliferation and differentiation - Insights from both in vivo and in vitro approaches 2010 6 31 35%
Exploring the native human antibody repertoire to create antiviral therapeutics 2008 11 159 28%
HUMAN MABS PRODUCED BY PRIMARY INVITRO IMMUNIZATION 1988 24 40 60%
HYBRIDOMA TECHNOLOGY - NEW DEVELOPMENTS OF PRACTICAL INTEREST 1987 32 90 53%
IMPROVED FUSION METHODS .4. TECHNICAL ASPECTS 1985 47 45 58%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 GENIE GENET CELLULAIRE 1 40% 0.2% 2
2 DEV AGING CANC AOBA KU 1 50% 0.1% 1
3 EA3515 1 50% 0.1% 1
4 KINGSTON REG 1 50% 0.1% 1
5 SCI TECHNOL ANAL SERV 1 50% 0.1% 1
6 SERV PROD TROUSSES RIA 1 50% 0.1% 1
7 THORAC SURG IMMUNOPHYSIOL 1 50% 0.1% 1
8 TB CANC IMMUNOL 1 29% 0.2% 2
9 HARVARD SURG S 0 33% 0.1% 1
10 HOSP HEMATOL 0 33% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000244641 SECT OBSTET GYNAECOL//PSEUDO HIV 1 PARTICLES//MOLONEY MURINE LEUKEMIA VIRUS MO MULV
2 0.0000126414 ELISA CELLULAR//MONOCLONAL ISLET CELL SURFACE ANTIBODIES MC ICSA//POLYETHYLENE IMPLANTS
3 0.0000114236 POLYVALENT ANTIGEN//AUTOLOGOUS ANTIBODY//B700
4 0.0000112473 PANDER//FAM3B//PANCREATIC DERIVED FACTOR
5 0.0000095024 IMMUNOGLOBULIN PRODUCTION STIMULATING FACTOR//HUMAN HUMAN HYBRIDOMA//IMMUNOGLOBULIN PRODUCTION STIMULATING FACTOR IPSF
6 0.0000079932 JOURNAL OF MOLECULAR AND CELLULAR IMMUNOLOGY//J11D//MED ICRF HUMAN TUMOUR IMMUNOL GRP
7 0.0000062595 PRISTANE//PAR GENE//PRISTANE INDUCED LUPUS
8 0.0000062497 EGG YOLK ANTIBODIES//ACTINOMYCIN C//HUMAN LIVER TISSUE
9 0.0000061117 NATURAL IGM ANTIBODIES//STEFAN ANGELOV MICROBIOL//ANTIBODY REPERTOIRES
10 0.0000057074 SOLID PHASE ANTIGEN//AFFINITY OF ANTIBODY//COMPLEX FORMATION RATE CONSTANT